Smoking, passive smoking and lung cancer cell types among women in Morocco: analysis of epidemiological profiling of 101 cases

BMC Research Notes

Errihani Hassan³  Mrabti Hind³  Razine Rachid²  Abahssain Halima³  Ouaouch Saloua³  Fatima Az-zahra Zakkouri¹ 

[1] Department of medical oncology, National Institute of Oncology, Agdal/Riad, Rabat, 10000, Morocco;Laboratory of Biostatistics, Epidemiology and Clinical Research, Rabat, Morocco;Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco

关键词: Survival;    Women;    Lung cancer;   

Others  :  1229878
DOI  :  10.1186/s13104-015-1503-3

 received in 2015-04-17, accepted in 2015-09-21,  发布年份 2015

【 摘 要 】

Background

Recently women’s lung cancer mortality rates have dramatically increased in developed countries, contrasting with a levelling off or decrease among men. Descriptive epidemiological data on primary lung cancer in women is scarce in Morocco. The aim of this study, conducted in the National Institute of Oncology in Rabat, was to describe the epidemiological profiling especially for the smoking status, to determine the most frequent type of lung cancer, and to analyse the survival of Moroccan women with lung cancer diagnosis.

Results

We found 101 women among 1680 (male and female) cases of lung cancer. The never-smokers were estimated to 75 %. The proportion of adenocarcinoma among never and passive smokers was higher than that of squamous cell carcinoma (SCC) (69.4 versus 30.6 %), while among women who were smokers, the most frequent histological type was SCC (63.6 %). The Cox regression analysis showed that smoking and passive smoking were not significantly associated with survival [HR: 0.62 (95 % CI 0.31, 1.30); p = 0.19] [HR: 0.56 (95 % CI 0.29, 1.08); p = 0.08] respectively. Adenocarcinoma was significantly associated with shorter survival [HR: 1.73 (95 % CI 1.05, 2.85); p = 0.03].

Conclusions

The majority Moroccan women affected by lung cancer have never smoked (75 %). Environmental exposures, genetic predisposition, hormonal factors, and viral infection may all play a role in lung cancer in this category. The relation between histological type and tobacco found in our series concurred with those reported in the literature—adenocarcinoma appears to be the most frequent cell type affecting never and passive smokers. Adenocarcinoma is significantly associated with poorer survival.

【 授权许可】

   
2015 Zakkouri et al.

【 图 表 】

Fig.1.

Fig.2.

【 参考文献 】

• [1]Kligerman Seth, White Charles: Epidemiology of lung cancer in women: risk factors, survival, and screening. AJR 2011, 196:287-295.
• [2]Rivera MP, Stover DE: Gender and lung cancer. Clin Chest Med 2004, 25:391-400.
• [3]Jemal A, Thun MJ, Ries LA, et al.: Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008, 100:1672-1694.
• [4]Benjaafar N, Tazi MA, Er-Raki A, et al. Moroccan Registry of Cancer. 2005:24–25.
• [5]Official website of the Foundation “Lalla Salma/prevention and treatment of cancer”. 2015.. http://www.contrelecancer.ma/fr/ webcite
• [6]Grivaux M, Breton JL, Bombaron P, Kuntz P, Lebas FX, Mehdaoui A, Herman D, David P, Berruchon J, Delclaux B, Zureik M, Blanchon F: Lung cancer among women in France. Analysis of the 904 French women with lung cancer included in the KBP-2000-CPHG study of the French College of General Hospital-based Pneumologists (CPHG). Lung Cancer 2004, 45:279-287.
• [7]Radzikowska E, Glaz P, Roszkowski K: Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20561 cases. Ann Oncol 2002, 13:1087-1093.
• [8]Rachtan J: Smoking, passive smoking and lung cancer cell types among women in Poland. Lung Cancer 2002, 35:129-136.
• [9]de Andrade M, Ebbert JO, Wampfler JA, Miller DL, Marks RS, Croghan GA, Jatoi A, Finke EE, Sellers TA, Yang P: Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer 2004, 43:127-134.
• [10]Lloyd-Jones D, Adams RJ, Brown TM, et al.: American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
• [11]Dresler CM, Fratelli C, Babb J, Everley L, Evans AA, Clapper ML: Gender differences in genetic susceptibility for lung cancer. Lung Cancer 2000, 30:15-60.
• [12]Cagle PT, Mody DR, Schwartz MR: Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res 1990, 50:6632-6635.
• [13]Mollerup S, Jorgensen K, Berge G, Haugen A: Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 2002, 37:153-159.
• [14]Weiss JM, Lacey JV Jr, Shu XO, et al.: Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 2008, 168:1319-1325.
• [15]Dougherty SM, Mazhawidza W, Bohn AR, et al.: Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. Endocr Relat Cancer 2006, 13:113-134.
• [16]Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. Lung Cancer 2009, 65:13-18.
• [17]Machiela MJ, Hsiung CA, Shu XO, Seow WJ, et al. Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia. Int J Cancer. 2015;137(2):311–9.
• [18]Alberg AJ, Ford JG, Samet JM: Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:29S-55S.
• [19]Bennett WP, Alavanja MCR, Blomeke B, Vahakangas KH, Castren K, Welsh JA, Bowman ED, Khan MA, Flieder DB, Harris CC. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 1999;91(23):2009–14.
• [20]Altekruse SF, Kosary CL, Krapcho M, et al, editors. SEER Cancer Statistics Review, 1975–2007. Bethesda: National Cancer Institute. http://seer.cancer.gov/csr/1975_2007. Based on November 2009 SEER data submission. Posted to the SEER Website 2010.
• [21]Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, editors. SEER survival monograph: cancer survival among adults: U.S. SEER program, 1988–2001: patient and tumor characteristics. NIH Publication no. 07-6215. Bethesda: National Cancer Institute; 2007.
• [22]Kligerman S, Abbott G: A radiologic review of the new TNM classification for lung cancer. AJR 2010, 194:562-573.